News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gilead Sciences, Inc. (GILD) Release: Vaginal Gel Cuts HIV Infections While Blocking Herpes


7/26/2010 3:37:30 PM

July 19 (Bloomberg) -- A vaginal gel containing Gilead Sciences Inc.’s AIDS drug Viread cut HIV infections by as much as 54 percent in a trial in South Africa, the first time such a product has protected women after six previous gels failed.

Read at Business Week

comments powered by Disqus
 
 
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES